MLKL Archives - Laboratory Notes

Necroptosis

admin — Fri, 28 Aug 2026 10:33:18 +0000

Necroptosis is a regulated necrotic cell‑death pathway driven by RIPK1–RIPK3–MLKL signalling. Through membrane permeabilisation and inflammatory activation, necroptosis eliminates infected or damaged cells when apoptosis is blocked, shaping immunity and disease progression.

The post Necroptosis appeared first on Laboratory Notes.

RIPK1

admin — Fri, 28 Aug 2026 10:19:09 +0000

RIPK1 is a central signalling kinase that determines whether a cell survives, undergoes apoptosis or triggers necroptosis. Through context‑dependent interactions with TNFR1, caspase‑8, RIPK3 and MLKL, RIPK1 integrates inflammatory cues and stress signals to regulate cell fate.

The post RIPK1 appeared first on Laboratory Notes.

RIPK3

admin — Fri, 28 Aug 2026 10:03:07 +0000

RIPK3 is a central necroptotic kinase that phosphorylates MLKL and drives regulated necrotic cell death. Through necrosome formation with RIPK1 and activation of inflammatory signalling, RIPK3 shapes immunity, tissue injury and disease progression.

The post RIPK3 appeared first on Laboratory Notes.

MLKL

admin — Thu, 27 Aug 2026 22:38:31 +0000

MLKL is the terminal effector of necroptosis. After phosphorylation by RIPK3, MLKL oligomerises and inserts into the plasma membrane, causing membrane rupture and release of inflammatory DAMPs. MLKL is essential for regulated necrotic cell death and immune activation.

The post MLKL appeared first on Laboratory Notes.